Literature DB >> 26564791

Combined Subscapularis Tears in Massive Posterosuperior Rotator Cuff Tears: Do They Affect Postoperative Shoulder Function and Rotator Cuff Integrity?

Jin-Young Park1, Seok Won Chung2, Seoung-Joon Lee2, Hyoung-Weon Cho2, Jae Hyung Lee1, Jun-Hee Lee2, Kyung-Soo Oh3.   

Abstract

BACKGROUND: Previous studies on massive rotator cuff tears have not addressed the outcomes of tears extending to the subscapularis tendon. HYPOTHESIS: The retear rate in patients with a massive posterosuperior rotator cuff tear combined with a subscapularis tear is higher than that in patients with a massive posterosuperior rotator cuff tear with an intact subscapularis tendon. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: Data were collected and analyzed from 92 consecutive patients who underwent arthroscopic repair of a massive posterosuperior rotator cuff tear. Patients were divided into 3 groups according to the status of the subscapularis tendon: intact subscapularis tendon (I-massive tear; n = 42), tear involving half or less than half of the subscapularis tendon (S-massive tear; n = 22), and tear involving more than half of the subscapularis tendon (L-massive tear; n = 28). The integrity of the rotator cuff was determined by ultrasonography at 4.5 and 12 months or later after surgery. Clinical evaluations were performed using the visual analog scale (VAS) pain score, the American Shoulder and Elbow Surgeons (ASES) score, the Constant score, and active shoulder range of motion. Data were collected on the day before surgery and at final follow-up (at least 24 months postoperatively).
RESULTS: A total of 25 retears (27%) were identified based on an ultrasonographic evaluation. Although statistical significance was not found, there was a trend toward a higher retear rate in patients with an L-massive tear (43%) compared with those with an S-massive tear (18%; P = .050) or I-massive tear (21%; P = .059) at final follow-up. The subclassification of retears according to the involved tendons revealed that subsequent retears of the subscapularis tendon were noted only in patients with an L-massive tear. In patients with an L-massive tear, postoperative data comparison between patients with intact subscapularis tendons and those with failed subscapularis tendons revealed that a significant difference was noted in the VAS (1.1 vs 3.8, respectively) and ASES (90.6 vs 58.5, respectively) scores. The improvement in clinical scores after repair was statistically significant in all groups but not different between the groups.
CONCLUSION: The arthroscopic repair of massive tears results in substantial improvements in shoulder function, regardless of the presence of combined subscapularis tears. However, this study showed a trend toward a high failure rate for the repair of massive posterosuperior rotator cuff tears extending over half of the subscapularis tendon. Therefore, other treatment options should also be considered for this type of rotator cuff tear.
© 2015 The Author(s).

Entities:  

Keywords:  integrity; massive tear; rotator cuff; subscapularis tear

Mesh:

Year:  2015        PMID: 26564791     DOI: 10.1177/0363546515610552

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  13 in total

1.  Can inadequate acromiohumeral distance improvement and poor posterior remnant tissue be the predictive factors of re-tear? Preliminary outcomes of arthroscopic superior capsular reconstruction.

Authors:  Seung-Jun Lee; Young-Kyoung Min
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-28       Impact factor: 4.342

2.  Diagnostic accuracy of ultrasound in subscapularis tendon abnormalities and the importance of operator experience.

Authors:  Uğur Toprak; Sefa Türkoğlu; Çiğdem Aydoğan; Emrah Kovalak; Suzan Saylısoy; Duygu Sıddıkoğlu; Akkan Mahmud
Journal:  Acta Orthop Traumatol Turc       Date:  2020-07       Impact factor: 1.511

3.  Prevalence and risk factors for development of subscapularis and biceps pathology in shoulders with degenerative rotator cuff disease: a prospective cohort evaluation.

Authors:  Siddhant K Mehta; Sharlene A Teefey; William Middleton; Karen Steger-May; Julianne A Sefko; Jay D Keener
Journal:  J Shoulder Elbow Surg       Date:  2020-03       Impact factor: 3.019

4.  Postoperative clinical outcomes and radiological healing according to deep and superficial layer detachment in first facet involving subscapularis tendon tear.

Authors:  Jung-Han Kim; Young-Kyoung Min; Man-Jun Park; Jung-Wook Huh; Jun-Ho Park
Journal:  Clin Shoulder Elb       Date:  2022-03-17

5.  National Trends in Surgery for Rotator Cuff Disease in Korea.

Authors:  Young Hoon Jo; Kwang Hyun Lee; Sung Jae Kim; Jaedong Kim; Bong Gun Lee
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

6.  Investigation of Growth Factor and Tenocyte Proliferation Induced by Platelet Rich Plasma (PRP) in a 3-Chamber Co-Culture Device.

Authors:  Chih-Hao Chiu; Rei Higashikawa; Wen-Ling Yeh; Kin Fong Lei; Alvin Chao-Yu Chen
Journal:  Micromachines (Basel)       Date:  2018-09-07       Impact factor: 2.891

7.  EFFECT OF SUBSCAPULARIS TEARS ON FUNCTIONAL SCORES OF PATIENTS UNDERGOING ROTATOR CUFF REPAIR.

Authors:  Eduardo Angeli Malavolta; Verônica Yulin Prieto Chang; Marcello Traballi Bozzi Pinto de Castro; Fernando Brandao Andrade-Silva; Jorge Henrique Assunção; Mauro Emilio Conforto Gracitelli; Arnaldo Amado Ferreira
Journal:  Acta Ortop Bras       Date:  2019 Mar-Apr       Impact factor: 0.513

8.  Which Factors Influence Clinical Outcomes After Superior Capsular Reconstruction Surgery?

Authors:  Seung-Jun Lee; Suk-Woong Kang; Ilkwon Chung; Hyungseo Jang
Journal:  Orthop J Sports Med       Date:  2020-12-16

9.  Bridging Graft in Irreparable Massive Rotator Cuff Tears: Autogenic Biceps Graft versus Allogenic Dermal Patch Graft.

Authors:  Sung Min Rhee; Joo Han Oh
Journal:  Clin Orthop Surg       Date:  2017-11-10

10.  Subscapularis tendon tears: Management and arthroscopic repair.

Authors:  Brett A Lenart; Jonathan B Ticker
Journal:  EFORT Open Rev       Date:  2017-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.